India set for cheaper Ozempic as key patent expires in March 2026
India’s pharmaceutical landscape is on the brink of a significant shift as the patent on semaglutide, ...
Read moreDetailsIndia’s pharmaceutical landscape is on the brink of a significant shift as the patent on semaglutide, ...
Read moreDetails© 2025 PGMN - Peanut Gallery Media News